Coldstream Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348K | Sell |
3,277
-399
| -11% | -$42.3K | 0.01% | 809 |
|
|
2025
Q1 | $456K | Buy |
3,676
+299
| +9% | +$37.1K | 0.01% | 650 |
|
|
2024
Q4 | $416K | Buy |
3,377
+1,077
| +47% | +$133K | 0.01% | 681 |
|
|
2024
Q3 | $259K | Buy |
2,300
+165
| +8% | +$18.6K | 0.01% | 910 |
|
|
2024
Q2 | $228K | Buy |
2,135
+299
| +16% | +$31.9K | 0.01% | 885 |
|
|
2024
Q1 | $221K | Sell |
1,836
-8
| -0.4% | -$963 | 0.01% | 908 |
|
|
2023
Q4 | $227K | Buy |
+1,844
| New | +$227K | 0.01% | 836 |
|
|
2023
Q2 | – | Sell |
-1,758
| Closed | -$257K | – | 847 |
|
|
2023
Q1 | $257K | Sell |
1,758
-58
| -3% | -$8.49K | 0.01% | 675 |
|
|
2022
Q4 | $289K | Buy |
+1,816
| New | +$289K | 0.01% | 611 |
|
|
2022
Q2 | $340K | Buy |
2,174
+826
| +61% | +$129K | 0.01% | 514 |
|
|
2022
Q1 | $210K | Buy |
+1,348
| New | +$210K | 0.01% | 732 |
|